Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4745 SEK | +2.15% | 0.00% | -9.27% |
16/04 | Mendus AB Announces Board Changes | CI |
27/03 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.27% | 44.24M | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- IMMU Stock
- News Mendus AB
- Immunicum Shares Down 28% on Decision to Cancel Further Trials for Cancer Drug